These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 32948837
1. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency. López I, Chalatsi E, Ellenbroek SIJ, Andrieux A, Roux PF, Cerapio JP, Jouvion G, van Rheenen J, Seeler JS, Dejean A. Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837 [Abstract] [Full Text] [Related]
2. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. He X, Lai Q, Chen C, Li N, Sun F, Huang W, Zhang S, Yu Q, Yang P, Xiong F, Chen Z, Gong Q, Ren B, Weng J, Eizirik DL, Zhou Z, Wang CY. Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635 [Abstract] [Full Text] [Related]
3. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A. J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659 [Abstract] [Full Text] [Related]
4. SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease. Mustfa SA, Singh M, Suhail A, Mohapatra G, Verma S, Chakravorty D, Rana S, Rampal R, Dhar A, Saha S, Ahuja V, Srikanth CV. Open Biol; 2017 Jun 15; 7(6):. PubMed ID: 28659381 [Abstract] [Full Text] [Related]
5. Spatiotemporal distribution of SUMOylation components during mouse brain development. Hasegawa Y, Yoshida D, Nakamura Y, Sakakibara S. J Comp Neurol; 2014 Sep 01; 522(13):3020-36. PubMed ID: 24639124 [Abstract] [Full Text] [Related]
6. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. Subramaniam S, Mealer RG, Sixt KM, Barrow RK, Usiello A, Snyder SH. J Biol Chem; 2010 Jul 02; 285(27):20428-32. PubMed ID: 20424159 [Abstract] [Full Text] [Related]
7. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency. Tahmasebi S, Ghorbani M, Savage P, Gocevski G, Yang XJ. Stem Cells; 2014 Apr 02; 32(4):1012-20. PubMed ID: 24706591 [Abstract] [Full Text] [Related]
9. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells. Yukita A, Hosoya A, Ito Y, Katagiri T, Asashima M, Nakamura H. Bone; 2012 May 02; 50(5):1092-9. PubMed ID: 22366399 [Abstract] [Full Text] [Related]
10. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, Jouvion G, Bomme P, Hamard G, Romagnolo B, Terris B, Cumano A, Barker N, Clevers H, Dejean A. Gastroenterology; 2011 Jan 02; 140(1):286-96. PubMed ID: 20951138 [Abstract] [Full Text] [Related]
11. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes. Prudden J, Perry JJ, Nie M, Vashisht AA, Arvai AS, Hitomi C, Guenther G, Wohlschlegel JA, Tainer JA, Boddy MN. Mol Cell Biol; 2011 Jun 02; 31(11):2299-310. PubMed ID: 21444718 [Abstract] [Full Text] [Related]
12. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS). Niedenthal R. Methods Mol Biol; 2009 Jun 02; 497():63-79. PubMed ID: 19107411 [Abstract] [Full Text] [Related]
13. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae. Klug H, Xaver M, Chaugule VK, Koidl S, Mittler G, Klein F, Pichler A. Mol Cell; 2013 Jun 06; 50(5):625-36. PubMed ID: 23644018 [Abstract] [Full Text] [Related]
14. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. McMillan LE, Brown JT, Henley JM, Cimarosti H. Neurosci Lett; 2011 Sep 20; 502(3):201-8. PubMed ID: 21843595 [Abstract] [Full Text] [Related]
15. Sumoylation of human argonaute 2 at lysine-402 regulates its stability. Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A. PLoS One; 2014 Sep 20; 9(7):e102957. PubMed ID: 25036361 [Abstract] [Full Text] [Related]
16. Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. Lee YJ, Mou Y, Maric D, Klimanis D, Auh S, Hallenbeck JM. PLoS One; 2011 Sep 20; 6(10):e25852. PubMed ID: 22016779 [Abstract] [Full Text] [Related]
17. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9. Yarahalli Jayaram V, Baggavalli S, Reddy D, Sistla S, Malempati R. Drug Chem Toxicol; 2020 Nov 20; 43(6):637-644. PubMed ID: 30426790 [Abstract] [Full Text] [Related]
18. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. Wu R, Fang J, Liu M, A J, Liu J, Chen W, Li J, Ma G, Zhang Z, Zhang B, Fu L, Dong JT. J Biol Chem; 2020 May 08; 295(19):6741-6753. PubMed ID: 32249212 [Abstract] [Full Text] [Related]
19. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic. Goffinont S, Coste F, Prieu-Serandon P, Mance L, Gaudon V, Garnier N, Castaing B, Suskiewicz MJ. J Biol Chem; 2023 Jul 08; 299(7):104870. PubMed ID: 37247759 [Abstract] [Full Text] [Related]
20. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1. Suda N, Shibata H, Kurihara I, Ikeda Y, Kobayashi S, Yokota K, Murai-Takeda A, Nakagawa K, Oya M, Murai M, Rainey WE, Saruta T, Itoh H. Endocrinology; 2011 Jun 08; 152(6):2266-77. PubMed ID: 21467194 [Abstract] [Full Text] [Related] Page: [Next] [New Search]